FDA
-
-
-
-
-
-
-
Veru to Report Fiscal Year 2025 Financial Results on December 17th
-
-
-
-
-
-
-
Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress
-
-
-
-
-
-
-
Veru to Report Fiscal 2025 Third Quarter Financial Results on August 12th
-
-
-
-
-
-
-
Veru Participates in a Virtual Investor KOL Connect Segment
-
-
-
-
-
-
-
Veru to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
-
-
-
-
-
-
-
Veru Announces Meta-analysis of Body Composition Data from Older Patients with Obesity which Supports Potential for Enobosarm to Optimize Weight Loss at ObesityWeek
-
-
-
-
-
-
-
Veru, Inc. (VERU) PT Lowered to $1 at Jefferies
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

